 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 2708 | 回復(fù): 4 | |||||||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||||||
[交流]
諾華上海研發(fā)中心招聘
|
|||||||
China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR) has some job vacancies as below. If you have interested in these jobs, please send your resume with no hesitation cause we'll provide you more chance to promote yourself in your field. Research Scientist-Liver Disease For more details, please click our career website: http://careers.novartis.com.cn/vacancies.html To apply this position, please send your resume to sarah.qi@novartis.com When you send your resume to sarah.qi@novartis.com, please notice you know this position information via 小木蟲BBS 諾華（中國）生物醫(yī)學(xué)研究有限公司是諾華全球研發(fā)組織――諾華生物醫(yī)學(xué)研究所（NIBR）的第八個研究基地。我們位于中國上海市張江高科技園區(qū)，將成為諾華在亞洲的主要研究中心，以及除在歐美的研究中心外的最主要的研究中心。我們的研究和探索開發(fā)活動的重點(diǎn)是發(fā)現(xiàn)并開發(fā)創(chuàng)新療法，用于治療在亞洲遠(yuǎn)未達(dá)到醫(yī)藥需求的疾病。我們與從不同之處在于將專注現(xiàn)代藥物的發(fā)現(xiàn)和開發(fā)方法的研究。最初階段，研發(fā)工作將專注在引起中國地方性癌癥的感染原因。我們還將開展臨床試驗(yàn)，進(jìn)行安全性研究，生物標(biāo)志物和檢測分析，表達(dá)譜、生物分析以及轉(zhuǎn)化醫(yī)學(xué)的研究。 隨著公司業(yè)務(wù)的迅速擴(kuò)展，我們熱忱歡迎您的加入。同時我們將提供具有競爭力的薪酬福利待遇以及良好的培訓(xùn)發(fā)展機(jī)會。 NIBR Shanghai NIBR Shanghai is an integrated research center that is part of the Novartis global research and development network. The establishment of this strategic site is a commitment by Novartis to conduct cutting-edge pharmaceutical research in China. Research activities at NIBR Shanghai focus on addressing urgent medical needs in China, particularly infectious causes of cancer endemic to the region. The center also established programs in epigenetics, biomarker development, drug metabolism and preclinical safety to support NIBR local and global R&D projects.Research at NIBR Shanghai is currently focused on discovering new therapies for infectious causes of cancer, such as liver cancer caused by HBV or HCV hepatitis. As the diseases are highly prevalent in the region, some one-third of the 400 million people infected with the hepatitis B virus are in China, with estimates that 300,000 people die from liver cancer in the mainland each year. A Growing and Dynamic Organization China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR), the legal entity for NIBR Research Center in Shanghai was launched in November 2006 and the start-up Research facilities opened in April 2007. Today, NIBR Shanghai has grown to an organization of about 260 associates including nearly 200 scientists. The research teams are comprised of both returnee scientists from abroad (about 20% of total scientists), and graduates from top tier universities, medical centers, and research institutes in China. Currently the center operates in an office building and two lab facilities in the Zhangjiang Hi-Tech Park. In the same area, the new Novartis Shanghai Campus is under design and construction. The first phase of the project will be completed by the end of 2014. |
回復(fù)此樓» 猜你喜歡
一志愿上海交大生物與醫(yī)藥專碩324分，求調(diào)劑
已經(jīng)有4人回復(fù)
-
一志愿重慶大學(xué)085700資源與環(huán)境，總分308求調(diào)劑
已經(jīng)有4人回復(fù)
-
0854電子信息求調(diào)劑 324
已經(jīng)有3人回復(fù)
-
303求調(diào)劑
已經(jīng)有3人回復(fù)
-
336求調(diào)劑
已經(jīng)有3人回復(fù)
-
306求調(diào)劑
已經(jīng)有9人回復(fù)
-
工科0856求調(diào)劑
已經(jīng)有4人回復(fù)
-
工科材料085601 279求調(diào)劑
已經(jīng)有10人回復(fù)
-
081700 調(diào)劑 267分
已經(jīng)有4人回復(fù)
-
276求調(diào)劑。有半年電池和半年高分子實(shí)習(xí)經(jīng)歷
已經(jīng)有9人回復(fù)
4樓2013-10-12 10:07:03
|
Research Scientist-Liver Disease Job Description China Novartis Institutes for Biomedical Research Co. Ltd (CNIBR) is currently seeking to fill a research scientist position in Biology Department. Self-motivated scientist with strong interest in drug discovery studies in liver diseases, esp in liver fibrosis/cirrhosis is welcome. The candidate will apply cell biology, molecular biology and biochemistry expertise on drug target validation, assay development, novel target identification as well as mechanistic studies. The candidate is expected to have the ability to handle multiple projects simultaneously and works in a fast-paced environment. Oral and written reports in English are also required regularly. Minimum requirements Candidates should hold an M.S./Ph.D. in Cell Biology, Molecular Biology, Developmental Biology or related field and have at least two years of relevant experience. Strong background and hands-on experience in liver diseases is preferred. The successful candidate is expected to have strong work ethic, excellent oral and written communication in English, and ability to function in an interdisciplinary team setting are essential. |
2樓2013-10-10 17:14:14
3樓2013-10-10 22:21:13
5樓2013-10-12 10:17:15
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 336求調(diào)劑 +3 | 收到VS 2026-03-20 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 298求調(diào)劑 +8 | 上岸6666@ 2026-03-20 | 8/400 |
|
|
|
[考研]
 一志愿東華大學(xué)化學(xué)070300，求調(diào)劑
+7
|
2117205181 2026-03-21 | 8/400 |
|
|
[考研] 尋找調(diào)劑 +4 | 倔強(qiáng)芒? 2026-03-21 | 4/200 |
|
|
|
[考研] 生物學(xué)調(diào)劑 +5 | Surekei 2026-03-21 | 5/250 |
|
|
|
[考研] 考研調(diào)劑 +4 | 來好運(yùn)來來來 2026-03-21 | 4/200 |
|
|
|
[考博] 招收博士1-2人 +3 | QGZDSYS 2026-03-18 | 4/200 |
|
|
|
[考研] 一志愿華中科技大學(xué)071000，求調(diào)劑 +4 | 沿岸有貝殼6 2026-03-21 | 4/200 |
|
|
|
[考研] 286分人工智能專業(yè)請求調(diào)劑愿意跨考！ +4 | lemonzzn 2026-03-17 | 8/400 |
|
|
|
[考研] 材料與化工（0856）304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-20 | 7/350 |
|
|
|
[考研] 307求調(diào)劑 +3 | 余意卿 2026-03-18 | 3/150 |
|
|
|
[考研] 303求調(diào)劑 +5 | 睿08 2026-03-17 | 7/350 |
|
|
|
[考研] 304求調(diào)劑 +6 | 曼殊2266 2026-03-18 | 6/300 |
|
|
|
[考研] 一志愿蘇州大學(xué)材料求調(diào)劑，總分315（英一） +5 | sbdksD 2026-03-19 | 5/250 |
|
|
|
[考研] 350求調(diào)劑 +5 | weudhdk 2026-03-19 | 5/250 |
|
|
|
[考研] 材料與化工專碩調(diào)劑 +7 | heming3743 2026-03-16 | 7/350 |
|
|
|
[考研] 一志愿中國海洋大學(xué)，生物學(xué)，301分，求調(diào)劑 +5 | 1孫悟空 2026-03-17 | 6/300 |
|
|
|
[考研] 085601材料工程專碩求調(diào)劑 +10 | 慕寒mio 2026-03-16 | 10/500 |
|
|
|
[考研] 材料工程專碩調(diào)劑 +5 | 204818@lcx 2026-03-17 | 6/300 |
|
|
|
[碩博家園] 湖北工業(yè)大學(xué) 生命科學(xué)與健康學(xué)院-課題組招收2026級食品/生物方向碩士 +3 | 1喜春8 2026-03-17 | 5/250 |
|